Novartis has announced plans to eliminate 1,960 jobs in its divisions in the United States over the next year.  The pharmaceutical giant said 1,630 sales positions in the field and 330 posts at its U.S. headquarters in New Jersey would be affected.  These actions follow the elimination of 1,400 U.S. sales positions in 2010 and the cutting of 900 development positions in October of 2011. Novartis...